Chronic Cough: Emerging Developments in the Therapeutic Landscape
November 30, 2022
November 29, 2023
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Vindico Medical Education.
This activity is supported by an educational grant from Merck & Co., Inc.
- Physicians — maximum of 1.25 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
The intended audience for this activity is otolaryngologists, allergists, pulmonologists, physician assistants, nurse practitioners, and other health care professionals involved in the management of patients with chronic cough.
Chronic cough—a cough lasting more than 8 weeks—impacts as much as 13% of the US population. It may be associated with a wide array of pulmonary or extrapulmonary conditions, and 70% of patients with this condition have at least 3 clinical encounters before an accurate determination of the etiology is made. More than half of patients who receive conventional treatment report that their symptoms remain uncontrolled, significantly affecting their daily activities and quality of life. With new agents on the horizon for managing unexplained and refractory chronic cough, it is vital that clinicians are poised to identify patients who may benefit from emerging therapies. In this educational symposium, featuring a Rapid-Fire Roundtable discussion, interdisciplinary experts will discuss the health and economic burden of chronic cough as well as its significant impact on patient quality of life. Faculty will review strategies for identifying the underlying causes, recommended approaches for empiric treatment, and clinical evidence on current and emerging therapies in this therapeutic landscape.
Upon completion of this activity, participants should be better able to:
- Assess the burden of chronic cough, including both health-related and economic burdens as well as quality-of-life considerations.
- Evaluate evidence-based strategies to recognize patients with chronic cough and identify the underlying causes of the condition.
- Summarize clinical evidence for the current and emerging therapies for chronic cough.
Kenneth W. Altman, MD, PhD, FACS
Chair, Department of Otolaryngology – Head & Neck Surgery
Geisinger Health System
Professor, Geisinger Commonwealth School of Medicine
Jonathan M. Bock, MD, FACS
Professor, Division of Laryngology & Professional Voice
Department of Otolaryngology & Communication Sciences
Medical College of Wisconsin
Peter Dicpinigaitis, MD, FCCP
Professor of Medicine, Albert Einstein College of Medicine
Division of Critical Care Medicine, Montefiore Medical Center
Director, Montefiore Cough Center
Rachel M. Taliercio, DO
Assistant Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Vice Chair, Department of Pulmonary Medicine
Institute Experience Officer
Respiratory Institute, Cleveland Clinic
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to meet the expectations of the American Board of Otolaryngology – Head and Neck Surgery’s Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation.
ABOHNS credits will be reported within approximately 30 days of successful completion of the activity.
This enduring material is approved for 1 year from the date of original release, November 30, 2022, to November 29, 2023
Disclosures of Conflicts of Interest
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
- Kenneth W. Altman, MD, PhD, FACS
- Advisor: Merck
- Consultant: Merck
- Speaker Contracted by Ineligible Company: Merck
- Independent Research Contractor: Bayer
- Jonathan M. Bock, MD, FACS
- Consultant: Merck
- Peter Dicpinigaitis, MD, FCCP
- Consultant: Bayer, Bellus, Merck, Shionogi
- Rachel M. Taliercio, DO
- Consultant: Merck
Reviewer reports the following relevant relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP, has no relevant financial relationships to disclose.
Vindico Medical Education Staff have no relevant financial relationships to disclose.
Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Certificates will be emailed to the participant.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
For CME questions please contact: CME@VindicoCME.com .